Annals of Internal Medicine, Ahead of Print.
Risultati per: Terapia antibiotica: breve durata vs. lunga durata
Questo è quello che abbiamo trovato per te
In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4
Annals of Internal Medicine, Ahead of Print.
In adults with TBI and anemia, liberal vs. restrictive RBC transfusion did not reduce unfavorable neurologic outcomes by 10% at 6 mo
Annals of Internal Medicine, Ahead of Print.
Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke
This noninferiority randomized clinical trial investigates whether tenecteplase is noninferior to alteplase for the treatment of Chinese patients with acute ischemic stroke eligible for intravenous thrombolysis within 4.5 hours after symptom onset.
La terapia del diabete mellito di tipo 1
Diagnosi, terapia e follow-up della malattia celiaca e della dermatite erpetiforme
Lactated Ringer vs Normal Saline Solution During Sickle Cell Vaso-Occlusive Episodes
This multicenter retrospective cohort study examines the comparative effectiveness of lactated Ringer solution vs normal saline for fluid resuscitation in inpatients with sickle cell disease and vaso-occlusive episodes.
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non–Small Cell Lung Cancer
This randomized clinical trial examines whether stereotactic body radiotherapy improves local control compared with hypofractionated conventional radiotherapy.
Transperineal vs Transrectal Prostate Biopsy
This randomized clinical trial compares the effect of transperineal vs transrectal prostate biopsy on infection rates after biopsy.
Linfoma mantellare, Aifa rende rimborsabile nuova terapia mirata
Tumore del sangue che in Italia colpisce 860 persone ogni anno
Transrectal vs. Transperineal Prostate Biopsy
In a randomized trial, procedure-related infection was less common with the transperineal approach.
Cancer Stage vs Mortality End Points in Randomized Clinical Trials of Cancer Screening
To the Editor A recent study provided a robust analysis of the association between the reduction in stage III to IV cancer diagnoses and overall survival gains in historical cancer screening trials, and the accompanying Editorial added an important epidemiological perspective. However, the relationship between cancer stage at diagnosis and survival is not static. Data from the studies examined, many of which were initiated 30 to 40 years ago, are of questionable relevance in the modern era.
Cancer Stage vs Mortality End Points in Randomized Clinical Trials of Cancer Screening
To the Editor A recent study offered valuable insights into the management and prognosis of advanced cancer. Nevertheless, we have several concerns about this article.
Cancer Stage vs Mortality End Points in Randomized Clinical Trials of Cancer Screening—Reply
In Reply Our study compared the end points of cancer-specific mortality and late-stage cancer in randomized clinical trials of cancer screening. Drs Kim and Gibbs write that the relationship between these could be affected by changes in cancer staging and treatment. We agree that this is true not only for our comparison of end points, but for cancer screening in general. For example, a screening test that is effective at reducing cancer mortality could become ineffective if new treatments decrease differences in survival between stages. For the cancer types in our study, Surveillance, Epidemiology, and End Results data generally show survival improvements over time across all stages.
Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial Fibrillation
This randomized clinical trial assesses the effect of pulmonary vein isolation vs a sham procedure on atrial fibrillation burden at 6 months in patients with symptomatic paroxysmal or persistent atrial fibrillation.
Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer
This randomized, multisite, comparative effectiveness trial investigates whether early palliative care delivered via video or in-person visits demonstrated equivalent effects on quality of life for patients with advanced non–small cell lung cancer and their caregivers.